444 related articles for article (PubMed ID: 11429329)
1. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
[TBL] [Abstract][Full Text] [Related]
2. Cardiac performance during vasopressin infusion in postcardiotomy shock.
Dünser MW; Mayr AJ; Stallinger A; Ulmer H; Ritsch N; Knotzer H; Pajk W; Mutz NJ; Hasibeder WR
Intensive Care Med; 2002 Jun; 28(6):746-51. PubMed ID: 12107681
[TBL] [Abstract][Full Text] [Related]
3. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
[TBL] [Abstract][Full Text] [Related]
5. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
[TBL] [Abstract][Full Text] [Related]
6. Arginine vasopressin in 316 patients with advanced vasodilatory shock.
Luckner G; Dünser MW; Jochberger S; Mayr VD; Wenzel V; Ulmer H; Schmid S; Knotzer H; Pajk W; Hasibeder W; Mayr AJ; Friesenecker B
Crit Care Med; 2005 Nov; 33(11):2659-66. PubMed ID: 16276194
[TBL] [Abstract][Full Text] [Related]
7. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial.
Torgersen C; Dünser MW; Wenzel V; Jochberger S; Mayr V; Schmittinger CA; Lorenz I; Schmid S; Westphal M; Grander W; Luckner G
Intensive Care Med; 2010 Jan; 36(1):57-65. PubMed ID: 19756505
[TBL] [Abstract][Full Text] [Related]
8. [Arginine-vasopressin in septic and vasodilatorial shock].
Dünser MW; Hasibeder WR; Wenzel V; Meier-Hellmann A
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Nov; 41(11):716-9. PubMed ID: 17151983
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
[TBL] [Abstract][Full Text] [Related]
10. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?
Dünser MW; Fries DR; Schobersberger W; Ulmer H; Wenzel V; Friesenecker B; Hasibeder WR; Mayr AJ
Anesth Analg; 2004 Jul; 99(1):201-206. PubMed ID: 15281530
[TBL] [Abstract][Full Text] [Related]
11. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
Agrawal A; Singh VK; Varma A; Sharma R
Indian J Pediatr; 2012 Apr; 79(4):488-93. PubMed ID: 21922300
[TBL] [Abstract][Full Text] [Related]
12. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
Buckley MS; MacLaren R
J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock.
Nygren A; Thorén A; Ricksten SE
Acta Anaesthesiol Scand; 2009 May; 53(5):581-8. PubMed ID: 19239407
[TBL] [Abstract][Full Text] [Related]
14. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
[TBL] [Abstract][Full Text] [Related]
15. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM; Chittock DR; Russell JA; Walley KR
Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
Lauzier F; Lévy B; Lamarre P; Lesur O
Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
[TBL] [Abstract][Full Text] [Related]
18. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
[TBL] [Abstract][Full Text] [Related]
19. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.
Dünser MW; Mayr AJ; Tür A; Pajk W; Barbara F; Knotzer H; Ulmer H; Hasibeder WR
Crit Care Med; 2003 May; 31(5):1394-8. PubMed ID: 12771608
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
